Login / Signup

Directions for new developments on statistical design and analysis of small population group trials.

Ralf-Dieter HilgersKit RoesNigel Stallardnull null
Published in: Orphanet journal of rare diseases (2016)
The main results from the three projects will constitute a useful toolbox for improved design and analysis of small population clinical trials. They address various challenges presented by the EMA/CHMP guideline as well as recent discussions about extrapolation. There is a need for involvement of the patients' perspective in the planning and conduct of small population clinical trials for a successful therapy evaluation.
Keyphrases
  • clinical trial
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • randomized controlled trial
  • prognostic factors
  • stem cells
  • mesenchymal stem cells
  • study protocol
  • cell therapy